Pennant Group Inc

Despite extreme overbought readings and price extended well above EMAs, the active Lockout Rally override indicates ongoing institutional demand and short-covering urgency. With Stage 2 advancing and rising EMAs providing structural support, bullish medium-term bias remains intact. Immediate participation is recommended to capture further continuation above the breakout zone, accepting the overextension under lockout dynamics.

• ↑Q1 ’26 revenue $285.4M (+36% YoY); home health revenue +43.3%.
• ↑“Strong Buy” consensus; $43.50 avg. target implies +8.6% upside.
• ↓Proposed 2026 Medicare reimbursement cuts may slash home health margins.